Minnesota State University, Mankato

Cornerstone: A Collection of Scholarly
and Creative Works for Minnesota
State University, Mankato
All Graduate Theses, Dissertations, and Other
Capstone Projects

Graduate Theses, Dissertations, and Other
Capstone Projects

2015

Hypothyroidism and the Development of Hypertension
Kaleb Short
Minnesota State University - Mankato

Follow this and additional works at: https://cornerstone.lib.mnsu.edu/etds
Part of the Cardiovascular Diseases Commons, Endocrine System Diseases Commons, and the
Endocrinology, Diabetes, and Metabolism Commons

Recommended Citation
Short, K. (2015). Hypothyroidism and the Development of Hypertension [Master’s thesis, Minnesota State
University, Mankato]. Cornerstone: A Collection of Scholarly and Creative Works for Minnesota State
University, Mankato. https://cornerstone.lib.mnsu.edu/etds/392/

This Thesis is brought to you for free and open access by the Graduate Theses, Dissertations, and Other Capstone
Projects at Cornerstone: A Collection of Scholarly and Creative Works for Minnesota State University, Mankato. It
has been accepted for inclusion in All Graduate Theses, Dissertations, and Other Capstone Projects by an
authorized administrator of Cornerstone: A Collection of Scholarly and Creative Works for Minnesota State
University, Mankato.

Hypothyroidism and the Development of Hypertension

By
Kaleb Fischer Short

A Thesis Submitted in Partial Fulfillment of the
Requirements for the Degree of
Master of Science
In
Biology

Minnesota State University, Mankato
Mankato, Minnesota
April 2015

Date_______________

Hypothyroidism and the Development of Hypertension
Kaleb Fischer Short
This thesis has been examined and approved by the following members of the student’s
committee.

________________________________
Dr. David Sharlin (Advisor)

________________________________
Dr. Penny Knoblich

________________________________
Dr. Michael Bentley

Abstract
Hypothyroidism and the Development of Hypertension
Name: Kaleb Fischer Short
Degree: Master of Science in Biology
Institution: Minnesota State University, Mankato
Mankato, Minnesota, 2015.

Low thyroid hormone (TH) in adulthood is associated with increased risk of
cardiovascular disease, including risk of hypertension. The Spontaneously Hypertensive
Rat (SHR), exhibits alterations in thyroid function when compared to normotensive
controls. Interestingly, inhibiting thyroid gland function before 4 weeks of age prevented
hypertension in the SHR, indicating that TH is involved in the etiology of SHR
hypertension. However, these studies utilized tail-cuff photoplethysmography (PPG),
which is known to have stress-induced artifacts, and did not compare effects in the
normotensive parent strain Wistar Kyoto (WKY) rat. Therefore, it is uncertain whether
TH is responsible for an elevation in baseline blood pressure or whether hypertension in
the SHR is caused by abnormal TH action in the cardiovascular system.
Considering this, the purpose of the present study was to investigate the effect of
hypothyroidism on the SHR and its parent strain, WKY on blood pressure. To study the
effect of thyroid hormone on blood pressure, we inhibited thyroid hormone production in
WKY and SHR male rats with 1% KClO4 and 0.05% MMI in drinking water from 4-14
weeks-of-age. Rats were allowed to recover from treatment weeks 14-17. Blood pressure
was monitored weekly by tail-cuff PPG from 4-15 weeks and by implantable remote
transmitters from 11-17 weeks. Pressure natriuresis was evaluated using flame
photometry.

PPG data was consistent with previous literature that indicated hypothyroidism
prevented hypertension in the SHR, but remote transmitter data indicated a comparable
reduction in systolic (SAP) and mean arterial pressure (MAP) between strains. The
observed difference in PPG can be explained by an exaggerated response of SAP to stress
in SHRs which is normalized by hypothyroid treatment. Strain differences were observed
in the effect of treatment on diastolic arterial pressure (DAP), pulse pressure (PP), heart
rate, and pressure natriuresis. Endothelial dysfunction and increased arterial stiffness in
the SHR provide potential explanations for differences in DAP, PP, and pressure
natriuresis.
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Introduction
Low thyroid hormone in adulthood is associated with increased risk of
cardiovascular disease (Rhee, Curhan, Alexander, Bhan, & Brunelli, 2013), including risk
of hypertension (Saito, Ito, & Saruta, 1983; Streeten, Anderson, Howland, Chiang, &
Smulyan, 1988). Interestingly, the Spontaneously Hypertensive Rat (SHR), a murine
model of hypertension, exhibits abnormal thyroid function when compared to
normotensive controls (Aoki, 1963a, 1963b; Fregly, 1975; Werner, Manger, Radichevich,
Wolff, & von Estorff, 1975; Yamabe, 1970). Additionally, thyroid gland inhibition
starting at 4 weeks of age has been found to prevent the onset of hypertension entirely in
the SHR, indicating that thyroid hormone is involved in the development of hypertension
(Aoki, 1963b; Rioux & Berkowitz, 1977).
Although these reports indicated involvement of thyroid hormone in the
establishment of hypertension in the SHR, the effect of hypothyroidism on blood pressure
has not been compared between the SHR and a normotensive strain. Therefore, it is
uncertain whether thyroid hormone is responsible for a baseline elevation in blood
pressure set point or whether hypertension in the SHR is caused by abnormal thyroid
action in the cardiovascular system.
Given the abnormal thyroid function in the SHR and prevention of hypertension
in the SHR by thyroidectomy in previous studies, it is hypothesized that: hypertension in
Spontaneously Hypertensive Rats is caused, in part, by abnormal thyroid hormone
action in the cardiovascular system.
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In testing this hypothesis, we propose that the inhibition of thyroid gland
activity will result in a greater overall decrease in mean arterial pressure in SHRs
when compared to controls, than the decrease found in WKY rats given the same
treatment.
Additionally, it is known that hypothyroidism induces reduced cardiac beta
adrenergic receptor numbers, subsequently decreasing sensitivity to sympathetic
stimulation (Bilezikian & Loeb, 1983; Rioux & Berkowitz, 1977). As tail-cuff
photoplethysmography evokes a stress response in rats, it is unclear whether the decrease
in systolic pressure in hypothyroid rats observed in prior studies is due to a basal
reduction in systolic pressure or due to a reduction in the stress-induced sympathetic
response. Prior research indicates that SHRs have higher sympathetic responsivity to
restraint than normotensive rats (Chiueh & Kopin, 1978). Therefore, it is hypothesized
that: hypothyroid rats exhibit a reduced response of systolic arterial pressure to
sympathetic stimulation. SHR hypothyroid rats will exhibit a greater reduction in
systolic arterial pressure in response to sympathetic stimulation than WKY
hypothyroid rats.
In testing this hypothesis, we propose that the inhibition of thyroid gland
activity will result in a smaller increase in systolic arterial pressure in response to
acute stress when compared to euthyroid counterparts. SHR hypothyroid rats will
exhibit a greater reduction in the systolic arterial pressure response to stress than
WKY hypothyroid rats when compared to their euthyroid counterparts.
Lastly, hypothyroidism impairs nitric oxide synthesis (Virdis et al., 2009). Nitric
oxide has a known effect on the pressure natriuresis response in rats (Guarasci & Kline,
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1996). Since prior studies have reported that chronic hypothyroidism has no effect on the
pressure natriuresis response in rats (Vargas, Atucha, Sabio, Quesada, & Garcia-Estan), it
is hypothesized that: developmentally hypothyroid rats will exhibit a comparable
pressure natriuresis response to euthyroid rats.
In testing this hypothesis, we propose that the inhibition of thyroid gland
activity at weaning will result in an acute pressure natriuresis response comparable
to that observed in euthyroid counterparts.
Literature Review
Thyroid Hormone Secretion and Regulation
Thyroid hormones, tetraiodothyronine (T4 or thyroxine) and triiodothyronine (T3),
are hormones synthesized by the thyroid gland, a gland which resembles a bow tie in
shape and size and is situated on the anterior side of the trachea. Iodine enters the
follicular cells of the thyroid gland by active transport and is covalently bound to tyrosine
residues within thyroglobulin, a glycoprotein synthesized within the follicular cells. This
covalent bonding is referred to as iodination and forms either monoiodotyrosine (MIT) or
diiodotyrosine (DIT). Two DIT molecules combine to form T4 and the combination of
one MIT and one DIT form T3. Ninety-five percent of thyroid hormone secreted by the
thyroid gland is T4 (Gard, 1998).
T4 binds to thyroid hormone receptors with less affinity than T3, and is often
thought of as a precursor to T3. The deiodinase enzymes function to remove iodine atoms
from iodothyronines as a mechanism of activation or deactivation within target tissues.
Type 2 deiodinase (D2), removes an iodine atom from the outer ring of T4 to create T3
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(activation). Type 3 deiodinase (D3) can remove an iodine atom from the inner ring of T4
to create reverse T3 (rT3) (inactivation) or remove an iodine atom from the inner ring of
T3 to create T2 (inactivation). Type 1 deiodinase (D1) is found most commonly in the
liver and kidney and can remove an iodine atom from either ring of thyroid hormones to
make T2, rT3, or T3 (Bates, St Germain, & Galton, 1999).
Circulating thyroid hormone in the blood is regulated via the hypothalamicpituitary-thyroid (HPT) axis. Thyrotropin releasing hormone (TRH) is produced by
neurons of the paraventricular nucleus of the hypothalamus. TRH stimulates the release
of thyroid stimulating hormone (TSH) production and release by the anterior pituitary.
TSH stimulates the thyroid gland to increase synthesizing activity of thyroid hormones.
Thyroid hormones act on the pituitary gland and hypothalamus to inhibit the release of
TSH and TRH, respectively, via a classical negative feedback loop (Gard, 1998).
Thyroid hormone receptors mediate the majority of biological processes regulated
by thyroid hormones. There are two extant thyroid receptor genes, TRα and TRβ. The T3
receptor product of TRα is TRα1 and is expressed primarily in the heart, brain, and
skeletal muscle. The T3 receptor products of TRβ are TRβ1, which is systemically
expressed, TRβ2, which is primarily expressed in the retina, brain, and inner ear, and
TRβ3, which is primarily expressed in the kidney, liver, and lung (Cheng, Leonard, &
Davis, 2010).
Arterial Pressure Regulation
Mean arterial pressure (MAP) is the average pressure in the arteries over one
cardiac cycle, which includes systole (ventricular contraction), and diastole, (ventricular
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relaxation/filling). Diastolic arterial pressure (DAP) is the minimum pressure in the
arteries in a cardiac cycle. Systolic Arterial Pressure (SAP) is the maximum pressure in
the arteries in a cardiac cycle. Pulse Pressure (PP) is the difference between SAP and
DAP.
MAP is a function of total peripheral resistance (TPR), the amount of resistance
that opposes blood flow in the systemic circulation, and cardiac output (CO), the amount
of blood pumped by the heart each minute (L/min). Cardiac output is the product of
stroke volume (SV), the amount of blood pumped from the ventricles of the heart in each
cardiac cycle (L), and heart rate (beats per minute (bpm)). Acutely, when a decrease in
MAP occurs, it stimulates the arterial baroreceptors, and the central nervous systems
enacts an increase in sympathetic stimulation. This increase in sympathetic stimulation
functions to increase heart rate, increase total peripheral resistance, and increase stroke
volume. Long-term, MAP is increased by the kidneys through increasing fluid and ion
reabsorption and decreasing fluid and ion excretion, resulting in an increase in blood
volume (Mohrman & Heller, 1997). The larger blood volume increases stroke volume,
and subsequently MAP.
Clinical Effects of Hypothyroidism on the Cardiovascular System
In the hypertensive population, there is a 30-50% increased prevalence of
hypothyroidism compared to the general population (Fletcher & Weetman, 1998;
Streeten et al., 1988). A review of published data indicates that hypertension occurs in
about 22% of hypothyroid patients compared to 3-18% of the general population (Danzi
& Klein, 2003). Clinical cardiovascular observations in hypothyroidism include
bradycardia, narrowed pulse pressure, and diastolic hypertension (I. Klein & Ojamaa,
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2001). Additionally, subclinical hypothyroidism has been reported as a risk factor for
atherosclerosis and myocardial infarction (Hak et al., 2000). A recent study found that
subclinical hypothyroidism and hypothyroidism were associated with a higher rate of allcause mortality in patients with congestive heart failure (Rhee et al., 2013). In most cases,
the effects of hypothyroidism on blood pressure are reversible with thyroid hormone
replacement (Fletcher & Weetman, 1998; Saito & Saruta, 1994).
Effects of Thyroid Hormone on the Heart
Thyroid hormone excess has been found to increase cardiac contractility in
humans (Amidi, Leon, DeGroot, Kroetz, & Leonard, 1968), rats (Korecky, Zak,
Schwartz, & Aschenbrenner, 1987), and cats (Buccino, Spann, Pool, Sonnenblick, &
Braunwald, 1967). The expression and subsequent production of phospholamban in
cardiomyocytes is negatively transcriptionally regulated, in part, by T3 (Kiss, Jakab,
Kranias, & Edes, 1994). Phospholamban regulates the active transport of Ca2+ into the
sarcoplasmic reticulum by the Ca2+-ATPase pump (SERCA2). Conditional SERCA2
knockout mice have severely impaired diastolic and systolic function (Louch et al.,
2010). Mice lacking phospholamban are observed to have increased cardiac contractility
and when treated with thyroid hormones, there was no additional increase in contractility.
This suggests that the relationship between cardiac contractility and thyroid hormones is
primarily mediated through phospholamban activity (Kiss et al., 1998). Overall, this
suggests T3 has an important influence on systolic contraction and diastolic relaxation
and provides a mechanistic explanation of clinical observations of reduced stroke volume
and narrowed pulse pressure in hypothyroid patients.
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Hypothyroidism reduces beta adrenergic receptors by 30-40% and increases
alpha-1 adrenergic receptors in the rat heart (Bilezikian & Loeb, 1983). This finding
would be consistent with clinical observations of bradycardia. Interestingly, it has been
found that changes in heart rate, contractility and blood pressure with changes in thyroid
hormone levels occur independently of the beta adrenergic receptor activity, indicating
the complex nature of these effects. (Bachman et al.).
Thyroid hormone positively regulates the alpha myosin heavy chain and
negatively regulates the beta myosin heavy chain in the heart (I. Klein & Danzi, 2007).
Thyroid receptor beta and alpha 1 are involved in the negative regulation of the beta
myosin heavy chain as well as the induction of the myosin heavy chain (Mansen, Yu,
Forrest, Larsson, & Vennstrom, 2001). Shifts from alpha to beta myosin in transgenic
mice have been found to reduce contractile function, increase systolic and diastolic
ventricular volumes (Krenz & Robbins, 2004). Together these findings outline changes in
myosin chain ratios associated with hypothyroidism as a potential mechanism of diastolic
dysfunction observed in hypothyroidism.
Hemodynamic Effects of Thyroid Hormone
T3 decreases vascular resistance acutely by dilating the arterioles (Park et al.,
1997). This is a direct relaxational effect of T3 on vascular smooth muscle cells (Ojamaa,
Klemperer, & Klein, 1996). Clinically, T3 has been administered to promote and facilitate
increases in cardiac output and vasodilation in the pathological failing heart and normal
heart in instances of advanced congestive heart failure (Hamilton et al., 1998) and in
coronary bypass patients (Klemperer et al., 1995). This relaxational effect can, in part, be
attributed to thyroid hormone involvement in the synthesis of nitric oxide, a vasodilator.

17

In hyperthyroidism, nitric oxide synthesis is enhanced and in hypothyroidism, nitric
oxide synthesis is impaired through thyroid hormone regulation of nitric oxide synthase
(Virdis et al., 2009).
Chronic and acute inhibition of nitric oxide synthase is reported to blunt the
response of sodium excretion to increases in blood pressure, or pressure natriuresis
(Guarasci & Kline, 1996). Since nitric oxide synthase inhibition is associated with
decreased pressure natriuresis and nitric oxide synthase is positively regulated by thyroid
hormone, augmented pressure natriuresis in hyperthyroidism and blunted pressure
natriuresis in hypothyroidism would be anticipated. However, hyperthyroidism blunts the
pressure natriuresis response in rats, but chronic hypothyroidism is not associated with an
alteration of the pressure natriuresis response (Vargas et al., 1994). This suggests that
alternative mechanisms regulating pressure natriuresis compensate (or in the case of
chronic hyperthyroidism, overcompensate) for chronic changes nitric oxide synthase
activity associated with altered thyroid states.
Additionally, hypothyroidism has been observed to decrease sensitivity of rat
aortic smooth muscle to alpha and beta adrenergic agonists (Rahmani, Cheema, Sen,
Peoples, & Riley, 1987; Rioux & Berkowitz, 1977). As the dominant effect of adrenergic
receptors in vascular smooth muscle is to constrict, the decrease in adrenergic sensitivity
resulting from hypothyroidism should have a vasodilatory effect and decrease resistance.
However, increased arterial stiffness and a related increase in systemic vascular
resistance and a subsequent increase in afterload are observed in hypothyroidism
(Obuobie et al., 2002). Increased afterload and systemic vascular resistance should result
in an increase in blood pressure.
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In hyperthyroidism, the decrease in systemic vascular resistance leads to a fall in
effective arterial filling volume, causing an increase in renin release and activation of the
renin-angiotensin system (Resnick & Laragh, 1982). An activation of the reninangiotensin system stimulates renal sodium absorption and a subsequent increase in
plasma volume (I. L. Klein, G.S., 2000). Additionally, thyroid hormone stimulates
erythropoiesis (Dainiak, Hoffman, Maffei, & Forget, 1978). In hyperthyroidism, the
combination of an increase in plasma volume and erythropoiesis results in an overall
increase in blood volume and preload. The opposite is true in a hypothyroid state and the
net effect of decreased preload and blood volume is a direct decrease in cardiac output (I.
Klein & Danzi, 2007). The combined direct effects of changes in preload, contractility,
heart rate and blood volume result in a 50-300 percent increase in cardiac output in
hyperthyroid individuals, compared to euthyroid counterparts and a 30-50 percent
decrease in cardiac output in hypothyroid individuals compared to euthyroid counterparts
(I. Klein & Danzi, 2007).
Thyroid Hormone in Nervous Control of the Cardiovascular System
In addition to local tissue effects of thyroid hormone in the cardiovascular system,
recent research implicates thyroid hormone involvement in central nervous control of
cardiac function (Fliers, Klieverik, & Kalsbeek, 2010). Injection of thyroid hormone into
the hypothalamus of rats inhibits the AMPK pathway and inhibits sympathetic nervous
system activity (Lopez et al., 2010), though studies of chronic inhibition of thyroid
activity indicate decreased response to sympathetic stimulation (Bilezikian & Loeb),
indicating that chronic vs. acute changes in thyroid state and local thyroid levels
determine the ultimate effect on sympathetic activity and responsiveness to sympathetic
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stimulation. Recently, a group of thyroid hormone sensitive neurons in the anterior
hypothalamus involved in cardiovascular regulation have been observed in decreased
numbers in mice with defective TRα1receptors. These mice were also observed to have a
permanent increase in blood pressure even after the administration of T3; indicating that
developmental thyroid signaling is critical in the establishment of cardiovascular
mechanisms involved in the regulation of blood pressure (Mittag et al., 2013).
Thyroid Function in the Rat Model of Hypertension
The Spontaneously Hypertensive Rat (SHR), a model of essential hypertension,
has altered thyroid function. A study of thyroid function in SHRs found plasma and
pituitary TSH were significantly elevated and plasma T4 was significantly lower in the
SHR when compared to normotensive WKY rats. Plasma T3, however, was found to be
normal. The monoiodotyrosine/diiodotyrosine ratio (MIT/DIT ratio) was found to be
elevated in the SHR, suggesting an abnormality in thyroidal synthesis of thyroid
hormones. Consistent with this idea, abnormalities in hydrolytic enzymes and
thyroglobulin were reported in SHRs (Kojima, Kubota, Sato, Yamada, & Harada, 1976).
Several studies report elevated thyroid secretion rates, though the same studies yield
equivocal results on iodine uptake and the rate of thyroidal radioactivity release (Fregly,
1975; Yamabe, 1970).
Adult offspring of gestationally hypothyroid normotensive rats are reported to
have elevated systolic, diastolic, and mean arterial pressure when compared with
euthyroid counterparts (Santos et al., 2012). Given the finding that SHRs are
hypothyroxinemic in comparison to normotensive strains, hypertension in the SHR may
be partially attributable to gestational hypothyroidism.

20

Most interestingly, radioactive thyroid ablation and thyroparathyroidectomy of 4
week old rats have been found to prevent the onset of hypertension in SHRs. Moreover,
thyroid hormone replacement in these animals was found to trigger a complete restoration
of hypertension in both studies. (Aoki, 1963b; Rioux & Berkowitz, 1977). However,
Rioux and Berkowitz found that thyroidectomy at 10 weeks of age did not significantly
reduce already present hypertension, though it prevented further development of
hypertension. Notably, despite the maintenance of established hypertension in rats
thyroidectomized at 10 weeks, heart rate was severely reduced. This suggests that thyroid
hormone is required for the development of elevated blood pressure, but removal of
thyroid hormone does not function to reverse an established elevation in blood pressure.
It is unclear whether thyroid hormone is generally responsible for an increased baseline
in blood pressure in all rats, or whether a specific abnormality in thyroid hormonemediated mechanisms in the SHR is responsible for the development of hypertension, as
the effect of thyroidectomy on blood pressure has not been compared between SHRs and
a normotensive strain.

Materials and Methods

Rat Strains
Spontaneously Hypertensive Rats (SHR) and Wistar Kyoto (WKY) Rats from MNSU’s
in house breeding program were used. They are descendants of rats supplied by both
Charles River Laboratories and Taconic.
Treatment
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At four weeks of age, male rats were weaned and divided into two test groups, euthyroid
(control group) and hypothyroid treatment. Control rats were administered tap water from
MNSU’s animal care facility. Hypothyroid rats were administered 0.05% methimazole
and 1.0% perchlorate in drinking water from MNSU’s animal care facility. All rats were
fed the standard LabDiet 5001 Rodent Diet. At postnatal week 14, a subset of
hypothyroid rats were removed from treatment and monitored to week 17 (WKY
Hypothyroid, SHR Hypothyroid (n=4 for each group)). A subset of control rats continued
to participate in the study through week 17 (WKY Control, SHR Control (n=4)). This
subset of rats will be referred to as the “recovery subset”.
Water and Mass Measurement
To determine that there was not a strain bias in water consumption between treatment
groups, water consumption was measured every two days for the first two weeks of
treatment. Mass was measured using a scale (US-BenchTop-PRO 200g + 0.1g balance).
Water consumption was measured by cage with each cage housing two rats. Individual
rats were weighted every two days and water consumption for each two day period was
divided by the total weight of the two rats. (WKY Control (cages=5), WKY Hypothyroid
(cages=5), SHR Control (cages=4), SHR Hypothyroid (cages=4)).
Weekly mass was measured using a US-BenchTop-PRO 200g + 0.1g balance
(WKY Control (n=17), WKY Hypothyroid (n=17), SHR Control (n=14), SHR
Hypothyroid (n=15)) from week 4 to week 14. Mass was also measured at week 17, the
end of the recovery period, in the recovery subset of animals.
Serum Collection and Measurement
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To confirm thyroid insufficiency in treatment rats, blood was collected at postnatal week
15 (WKY Control, WKY Hypothyroid, SHR Control, SHR Hypothyroid (n=6/group)).
To confirm thyroid hormone recovery, blood was collected at postnatal week 17 in the
recovery subset (WKY Control, WKY Hypothyroid, SHR Control, SHR Hypothyroid
(n=4/group)). The rats were first anesthetized in an anesthetic chamber using isoflurane
(3% in oxygen) followed by right ventricular puncture using a 22g needle and 10 mL
syringe to collect blood. Blood was placed into a serum separator test tube, allowed to
coagulate for 20 minutes, and then centrifuged at 1100-2000 RCF for 10 minutes. Serum
was placed into microcentrifuge tubes and frozen at -18 degrees Celcius until assay.
Serum T4 was measured using Diagnostic Automation competitive enzyme-linked
immunosorbant assay (ELISA) test kits. 25 μL of 0, 0.05, 1, 2, 5, 10, 15, and 25 μg/dL
standards and serum samples were pipetted into coated wells. 100 μL of working
conjugate reagent was pipetted into each well and mixed thoroughly for 30 seconds, then
incubated at room temperature for 60 minutes. Following incubation, well contents were
removed and rinsed 5 times with distilled water. 100 μL of TMB reagent was pipetted
into each well and contents were gently mixed for 5 seconds, then incubated in the dark
for 20 minutes. 100 μL of stop solution was pipetted into each well and wells were
gently mixed for 30 seconds. Absorbance was read at 450 nm with a Thermo Scientific
Multiskan Spectrum Microplate Photometer. Standard values were used to generate a
standard curve and concentration values were interpolated for serum samples using the
standard curve.
Occlusion Tail-Cuff Photoplethysmography
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Starting at postnatal week 4, systolic arterial pressure (SAP) was recorded weekly in a
subgroup or rats via tail-cuff photoplethysmography (WKY Control (n=10), WKY
Hypothyroid (n=9), SHR Control (n=8), SHR Hypothyroid (n=10)). Rats were carefully
placed in clear plastic restraining chambers to limit movement during data collection.
Rats were placed under a heat lamp to facilitate clear pulse detection, and IITC Life
Science tail-cuff photoplethysmography sensors were placed on the rats’ tails. BioPac
software was used to interface between the IITC plethysmography units and a computer,
which recorded pulse and pressure. Once a pulse was detected, the tail cuff was inflated
to 300 mmHg, or until a pulse wave was no longer detected. The tail cuff was then slowly
deflated until the pulse was again detected. The blood pressure at the reappearance of the
pulse wave is equal to systolic arterial pressure. This process was repeated for a total of
six pressure readings. Rats were then returned to their housing. The last three clear
systolic pressures were averaged for each rat to determine the weekly SAP value. This
procedure was continued to postnatal week 15.
Remote Monitoring of Blood Pressure
At postnatal week 10, a subgroup of rats was implanted with remote monitoring blood
pressure transmitters to more accurately measure unstressed blood pressure. Rats greater
than 150 grams at the time of implant were implanted with Data Sciences International
TA11PA-C40 PhysioTel transmitters (WKY Control (n=8), WKY Hypothyroid (n=6),
SHR Control (n=6). Due to growth retardation associated with hypothyroid treatment,
some rats were less than 150 grams at the time of implant, and therefore were implanted
with much smaller Data Sciences International TA11PA-C10 PhysioTel transmitters
(WKY Hypothyroid (n=1), SHR Hypothyroid (n=7)).
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For implantation, rats were placed in an anesthetic chamber and anesthetized with
isoflurane (3% in oxygen). Rats were then removed from the chamber, a mask was placed
over the nose and mouth, and isoflurane anesthesia was maintained at an appropriate
depth. Sterile techniques were followed for all surgical procedures. The inner surface of
the thigh was shaved and scrubbed with chlorhexidine, a disinfectant scrub. The rat was
placed on a heating pad, temperature was recorded rectally, and rectal temperature was
maintained at 37 degrees Celsius by adjusting the heating pad control. An inguinal
incision was made, the femoral artery was gently isolated, and the catheter from the
remote monitoring device was inserted into a branch of the femoral artery and advanced
into the descending aorta. The C40 transmitter was placed subcutaneously on the rat’s
side. The C10 transmitter was placed subcutaneously on the ventral surface of the
abdomen. The catheter was tied in place with 4-0 silk, and the skin closed with 4-0 nylon.
The rat received an injection of Rimadyl (caprofen) (10 mg/kg) to control post-op pain.
The rat was allowed to recover for at least 5 days before data collection began.
Data was collected from postnatal week 11 to postnatal week 14 (WKY Control
(n=8), WKY Hypothyroid (n=7), SHR Control (n=6), SHR Hypothyroid (n=7)). The
transmitters sent a radio signal to a receiver attached to a computer. Blood pressure was
monitored in 10 second segments, once an hour, for 48 successive hours out of each
week. Batteries were be shut off during the days the rats were not monitored to conserve
battery life. Batteries were turned off or on by waiving a magnet over the surface of the
rat.
Stress Test
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As a measure of sympathetic response, the recovery subset of rats (WKY Control, WKY
Hypothyroid, SHR Control, SHR Hypothyroid (n=4 for each group)) was subjected to a
stress test at weeks 14 and 17. Heart rate and pressure were sampled continuously via
remote transmitter for 50 seconds in undisturbed rats for a baseline recording. The rat
was then placed in a restrainer and the proximal tail was held while heart rate and blood
pressure were sampled continuously for 50 seconds. The rat was then returned to its
housing. Stress response was determined as a measure of change from baseline average to
stressed average in heart rate and pressure.
Na+ Excretion
Pressure natriuresis was measured acutely in a subgroup of rats (WKY Control
(n=6), WKY Hypothyroid (n=6), SHR Control (n=6), SHR Hypothyroid (n=5)). The rat
was anesthetized using isoflurane anesthetic gas (3% in oxygen) and administered Inactin
(thiobutabarbital) (100 mg/kg) intraperitoneally once anesthetized. The ventral abdomen
and neck were shaved. The rat was placed on a heating pad, temperature was recorded
rectally, and rectal temperature was maintained at 37 degrees Celsius by adjusting the
heating pad control. An incision was made on the ventral neck and a breathing tube (PE
240) was inserted into the trachea, a cannula (PE 50) was inserted into the jugular vein
for saline infusion (12 mL/kg/hr) to maintain fluid balance, and a cannula (PE 50) was
inserted into the carotid artery and connected to a blood pressure transducer which was
connected to BIOPAC hardware which interfaced with a computer for recording blood
pressure and heart rate. The abdomen was opened, and ligation sutures were pre-placed
around the mesenteric and celiac arteries, and the lower aorta, caudal to the renal (kidney)
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arteries. For urine collection, a tube (PE 240) was placed into the bladder lumen and
stabilized with a purse string suture.
After a 30-minute period of equilibration, blood pressure was recorded
continuously on the computer. Urine was gently aspirated from the bladder tube and
bladder at the end of each period, measured, and stored at 3 degrees Celsius until
analysis. A baseline fifteen-minute urine sample was collected from all rats in both
groups. Following the baseline period, the artery ligation sutures were tied off, which
caused a rise in blood pressure. Urine and blood pressure readings were collected for
three additional fifteen-minute periods. Urine samples were measured and diluted to 0.3
mL. 1:100 dilutions of samples were prepared with a Jenway Series 7 Diluter. Sodium in
urine samples was measured using a Jenway PFP7 Flame Photometer, and pressure
natriuresis was compared within each strain between control and hypothyroid groups.
Data Analyses
Repeated measures two-way ANOVAs followed by a Bonferroni post hoc tests were used
to determine if there was a significant effect of treatment (hypothyroid or control) or
strain (SHR or WKY) on mean arterial pressure, diastolic pressure, systolic pressure,
pulse pressure and heart rate. Two separate repeated measures two-way ANOVAs were
used for data for weeks 11-14 of treatment and the recovery subset through week 17.
Weekly blood pressure measurements were normalized by calculating the
difference between the actual pressure, and the group mean. A repeated measures twoway ANOVA, followed by a Bonferroni post hoc test was used to determine if there was
a significantly difference between strains in hypothyroid effects on mean arterial
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pressure, diastolic pressure, systolic pressure, pulse pressure and heart rate. Weeks 11-14
of treatment, and the recovery subset through week 17 were analyzed separately.
A one-way ANOVA followed by a Bonferroni post hoc test was used to
determine if there was a significant effect of strain or treatment on serum T4 at weeks 14
and 17.
A two-way ANOVA followed by a Bonferroni post hoc test was also used to
determine if there was a significant effect of strain or treatment on urine volume
excretion or Na+ excretion when blood pressure was raised.
Tertiles of activity were determined for each strain/treatment group. Mean
diastolic arterial, systolic arterial, mean arterial, and pulse pressures and heart rate were
determined for high, low, and medium tertiles. For each animal, low means were
subtracted from high means to determine and compare differences in pressure and heart
rate base on activity. Repeated measures two-way ANOVAs followed by a Bonferroni
post hoc tests were used to determine if there was a significant effect of treatment
(hypothyroid or control) or strain (SHR or WKY) on differences between high and low
activity values for mean arterial pressure, diastolic pressure, systolic pressure, pulse
pressure and heart rate. Data for weeks 11-14 of treatment and the recovery subset
through week 17 were analyzed separately.
Results
Serum T4
Figure 1 summarizes mean serum T4 for animals sacrificed at postnatal week 14
and postnatal week 17. Serum T4 was significantly lower in WKY hypothyroid rats and
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SHR hypothyroid rats compared to their respective controls at week 14 as well as
significantly lower T4 in SHR controls than in WKY controls at week 14. No significant
differences were detected between any groups in the recovery subset sacrificed at week
17.
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SHR Control (n=6;4)
WKY Hypothyroid (n=6;4)
SHR Hypothyroid (n=6;4)
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Age (week)
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Figure 1. The effect of strain and treatment on serum T 4 as measured by ELISA. Bars represent mean
serum T4 ± standard error at postnatal weeks 14 and 17. *p<0.05 between SHR controls and WKY
controls ***p<0.001 when hypothyroid rats are compared to control rats of the same strain. (n=week
14;week 17)

Weights
Figure 2 summarizes mean weekly weights at postnatal week 4 through 14. WKY
hypothyroid rats and SHR hypothyroid rats had significantly lower weights compared
to their respective controls from week 6 through week 14.
Figure 3 summarizes mean weight gain between week 14 and 17 in the recovery
subset. SHR control rats experienced a significantly lower weight gain compared to
WKY hypothyroid rats. No significant differences were detected between any other
groups.
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Figure 2. The effect of strain and treatment on weight. Bars represent mean weight ± standard error at
postnatal weeks 4-14. ***p<0.001 when hypothyroid rats are compared to control rats of the same
strain.
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Figure 3. The effect of strain and treatment on weight gain between weeks 14 and 17 in the recovery
subset. Bars represent mean weight gain ± standard error. *p<0.05 between SHR control and WKY
hypothyroid rats.

Systolic Arterial Pressure by Tail-Cuff Photoplethysmography
Figure 4 summarizes mean weekly systolic arterial pressures at postnatal week 4
through 15 as measured by tail-cuff photoplethysmography. SHR hypothyroid rats had
significantly lower systolic arterial pressures compared to SHR controls weeks 6-15.
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WKY hypothyroid rats had significantly lower systolic arterial pressures compared to
WKY controls at weeks 5, 7, 11-13. WKY treatment groups exhibited a significantly
lower difference in systolic arterial pressure than that between SHR treatment groups at
weeks 4, 8, 9, 11, and 13-15.

WKY Hypothyroid (n=8)

ns

ns

***

**

***

+++

+++

***

***

ns
*
13

ns

***

12

**

***

10

*

ns

***

9

***

***
***

8

**

7

ns

ns

6

+
ns

+++

11

+++

++

ns

15

WKY Control (n=10)

14

SHR Hypothyroid (n=10)

+++

5

275
250
225
200
175
150
125
100
75
50

4

Systolic Pressure (mmHg)

SHR Control (n=8)

Age (week)

Figure 4. The effect of strain and treatment on systolic arterial pressure as measured by tail-cuff
photoplethysmography. Bars represent mean systolic arterial pressure ± standard error at postnatal weeks 415. *p<0.05, **p<0.01, ***p<0.001 when hypothyroid rats are compared to control rats of the same strain.
+p<0.05, ++p<0.01, +++p<0.001 when the magnitude of difference between control and hypothyroid rats is
compared between SHR and WKY strains.

Pressure and Heart Rate by Remote Transmitter
Figure 5 summarizes mean weekly mean arterial pressures at postnatal week 11
through 17 as measured by remote transmitter. Both the SHR and WKY hypothyroid rats
had significantly lower mean arterial pressures compared to their respective controls
weeks 11-14. SHR hypothyroid rats in the recovery subset had significantly lower mean
arterial pressures compared to SHR controls weeks 15-17. WKY hypothyroid rats in the
recovery subset had significantly lower mean arterial pressures compared to WKY
controls at weeks 15-17. In the hypothyroid SHR, MAP decreased significantly during
recovery, when compared to week 14. No significant differences were found between
strains in mean arterial pressure changes in response during treatment or recovery.
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Figure 6 summarizes mean weekly systolic arterial pressures at postnatal week 11
through 17 as measured by remote transmitter. Both the SHR and WKY hypothyroid rats
had significantly lower systolic arterial pressures compared to their respective controls
weeks 11-14. Both the WKY and SHR hypothyroid rats in the recovery subset had
significantly lower systolic arterial pressures compared to their respective controls weeks
15-17. No significant differences were found between strains in systolic arterial pressure
response during treatment or recovery.
Figure 7 summarizes mean weekly diastolic arterial pressures at postnatal week
11 through 17 as measured by remote transmitter. Diastolic pressure was not significantly
different in SHR hypothyroid rats compared to SHR controls weeks 11-14, but WKY
hypothyroid rats had significantly lower diastolic arterial pressures compared to WKY
controls at weeks 11-14. SHR hypothyroid rats in the recovery subset had significantly
lower diastolic arterial pressures compared to SHR controls weeks 16-17, but diastolic
pressure, although remaining low, was not significantly different in WKY hypothyroid
rats in the recovery subset compared to WKY controls at weeks 15-17. When compared
to SHR, WKY rats exhibited a significantly greater change in diastolic arterial pressure in
response to treatment weeks 11-14. In hypothyroid SHR, diastolic pressure decreased
significantly during recovery, when compared to week 14. No significant differences
were found between strains in the change in diastolic arterial pressure in response to
treatment withdrawal weeks 15-17.
Figure 8 summarizes mean weekly pulse pressures at postnatal week 11 through
17 as measured by remote transmitter. Both the WKY and SHR hypothyroid rats had
significantly lower pulse pressures compared to their respective controls weeks 11-14.
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SHR hypothyroid rats in the recovery subset had significantly lower pulse pressures
compared to SHR controls at week 15. WKY hypothyroid rats in the recovery subset had
significantly lower pulse pressures compared to WKY controls at week 17. SHRs
exhibited a significantly greater response of pulse pressure to treatment compared to
WKY rats weeks 11-14. The recovery subset of SHRs exhibited a significantly greater
change in pulse pressure in response to treatment compared to the recovery subset of
WKY rats at week 15. In the hypothyroid SHR, pulse pressure increased significantly
during recovery when compared to week 15.
Figure 9 summarizes mean weekly heart rate at postnatal week 11 through 17 as
measured by remote transmitter. Both the WKY and SHR hypothyroid rats had
significantly lower heart rates compared to their respective controls weeks 11-14. WKY
rats exhibited a significantly greater change in heart rate in response to treatment
compared to SHRs weeks 12-14. No significant differences were found between strains
in response of heart rate to treatment withdrawal weeks 15-17.
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Figure 5. The effect of strain and treatment on mean arterial pressure as measured by remote transmitter.
Bars represent mean, mean arterial pressure ± standard error at postnatal weeks 11-17. *p<0.05, **p<0.01,

33
***p<0.001 when hypothyroid rats are compared to control rats of the same strain. (n=week 11-14;week
15-17)
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Figure 6. The effect of strain and treatment on systolic arterial pressure as measured by remote transmitter.
Bars represent mean systolic arterial pressure ± standard error at postnatal weeks 11-17. *p<0.05,
**p<0.01, ***p<0.001 when hypothyroid rats are compared to control rats of the same strain. (n=week 1114;week 15-17)
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Figure 7. The effect of strain and treatment on diastolic arterial pressure as measured by remote transmitter.
Bars represent mean diastolic arterial pressure ± standard error at postnatal weeks 11-17. *p<0.05,
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Figure 8. The effect of strain and treatment on pulse pressure as measured by remote transmitter. Bars
represent pulse pressure ± standard error at postnatal weeks 11-17. *p<0.05, **p<0.01, ***p<0.001 when
hypothyroid rats are compared to control rats of the same strain. +p<0.05, ++p<0.01, +++p<0.001 when the
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Figure 9. The effect of strain and treatment on heart rate as measured by remote transmitter. Bars represent
mean heart rate ± standard error at postnatal weeks 11-17. *p<0.05, **p<0.01, ***p<0.001 when
hypothyroid rats are compared to control rats of the same strain. +p<0.05, ++p<0.01, +++p<0.001 when the
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Activity Differences
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Figure 10 summaries mean difference between heart rate at high and low tertiles
of activity as measured by remote transmitter. Hypothyroid SHRs and hypothyroid
WKYs had a significantly blunted response of heart rate to increased activity compared
to their respective controls weeks 11-14. No significant differences in heart rate response
to increased activity were found between any groups at weeks 15-17.
No significant differences were detected between any groups in mean difference

100
80

***

***

***

***

WKY Control (n=4)
WKY Hypothyroid (n=4)
SHR Control (n=4)
SHR Hypothyroid (n=4)

***

***
60
40
20

***

**
17

16

15

14

13

12

0
11

 High and Low Activity (BPM)

between high and low activity for parameters other than heart rate.

Age (week)

Figure 10. The effect of strain and treatment on difference between heart rate at high activity and low
activity at weeks 11-17 as measured by remote transmitter. Bars represent mean difference between high
activity and low activity ± standard error at postnatal weeks 11- 17. **p<0.01, ***p<0.001 when
hypothyroid rats are compared to control rats of the same strain.

Stress Test
Figure 11A summarizes mean differences between resting and stressed systolic
arterial pressure as measured by remote transmitter. SHR controls had a significantly
greater increase in systolic arterial pressure with stress than WKY controls at weeks 14
and 17, and a significantly greater increase in systolic arterial pressure with stress than
SHR hypothyroid rats at week 14. During recovery at week 17, SHR hypothyroid rats had
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a significantly greater increase in systolic arterial pressure with stress than WKY
hypothyroid rats.
Figure 11B summarizes mean difference between resting and stressed pulse
pressure as measured by remote transmitter. SHR controls had a significantly greater
increase in pulse pressure with stress than WKY controls at weeks 14 and 17, and a
significantly greater increase in pulse pressure with stress than SHR hypothyroid rats at
week 14.
No differences were found between any groups in the effects of stress on heart
rate, mean arterial pressure, or diastolic pressure.
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Figure 11. The effect of strain and treatment on difference between resting and stressed systolic arterial
pressure (A) and pulse pressure (B) as measured by remote transmitter. Bars represent mean systolic
arterial pressure (A) and pulse pressure (B) ± standard error at postnatal weeks 14 and 17. *p<0.05

Pressure Natriuresis
Figure 12 summarizes mean Na+ excretion at four 15 minute periods at postnatal
week 15 as measured by flame photometer. WKY hypothyroid rats had significantly
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higher pressure natriuresis compared to WKY controls periods 2-4, and sodium excretion
was greater than baseline values during period 4.
No significant differences were found between any groups in urine volume
excretion.
Figure 13 summarizes mean arterial pressure at eight 7.5 minute intervals at
postnatal week 15 as measured by BIOPAC hardware. No significant differences in mean
arterial pressure were found between WKY hypothyroid and SHR hypothyroid rats and
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Figure 12. The effect of strain and treatment on Na + excretion as measured by flame photometer. Bars
represent mean Na+ excretion ± standard error at each 15 minute period at postnatal week 14. *p<0.05,
**p<0.01, ***p<0.001 when WKY hypothyroid rats are compared to WKY control rats. Arrow represents
ligation of celiac and mesenteric arteries and abdominal aorta caudal to the kidneys.
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Figure 13. The effect of strain and treatment on pressure response as measured by BIOPAC hardware. Bars
represent mean, mean arterial pressure ± standard error at 7.5 minute intervals at postnatal week 14. Arrow
represents ligation of celiac and mesenteric arteries and abdominal aorta caudal to the kidneys.

Discussion
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Induction of hypothyroidism in experimental animals with methimazole and
perchlorate treatment was confirmed by measuring a reduction in total serum T4.
Furthermore, treated animals exhibited severe growth retardation, an effect consistent
with overt developmental hypothyroidism. When treatment was withdrawn, serum T4 was
normalized and weight was gained at a rate that was similar to their respective controls,
suggesting of a return to euthyroid status.
Consistent with previous results (Aoki, 1963b; Rioux & Berkowitz, 1977), tailcuff photoplethysmography indicated that hypothyroidism induced at weaning prevented
the development of hypertension in SHR. However, in WKY rats, the effect of
hypothyroidism on systolic blood pressure was minimal. Conversely, remote transmitter
data showed a comparable reduction of systolic arterial pressure and mean arterial
pressure in hypothyroid SHRs and hypothyroid WKY rats when compared to their
respective controls. The stress test data provide a potential explanation for the
discrepancy between tail-cuff photoplethysmography and remote transmitter data. SHR
control rats exhibited a much greater increase in systolic arterial pressure under stressed
conditions than WKY rats, but this exaggerated response was absent in the hypothyroid
SHRs. Thus, during tail cuff photoplethysmography, the stressed systolic arterial pressure
in the control SHRs was much higher than that of the hypothyroid SHRs, which did not
exhibit an exaggerated stress response, resulting in an exaggerated difference in the
systolic arterial pressures between SHR controls and SHR hypothyroid animals.
Potential explanations of the reduction of pressure in response to stress observed
in hypothyroid SHRs are decreased sensitivity to adrenergic stimulation, lower blood
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volume, and reduced maximum cardiac output of the heart due to morphological changes
associated with hypothyroidism. Prior research indicates that the effects of thyroid
hormone on the heart, in stress-free environment, are independent of the beta adrenergic
receptors (Bachman et al.). Additionally, the present study found that pressure changes
associated with changes in activity were normal, indicative of a normal response despite a
reduction in baseline pressures. These observations support the idea that the reduction in
stress-induced response of systolic blood pressure is due to morphological changes
resulting in a reduction in cardiac output. However, it cannot be ruled-out that alterations
in adrenergic signaling occur in the hypothyroid state; resulting in a lower the maximum
sympathetic response to a stressful environment.
During treatment, diastolic arterial pressure was reduced in hypothyroid WKY
animals compared to WKY controls, but hypothyroid SHRs did not display significantly
lower diastolic arterial pressure compared to control SHRs. However, when treatment
was withdrawn, the diastolic arterial pressures of the SHR hypothyroid rats dropped and
were significantly lower than those of the SHR controls. WKY hypothyroid rats were not
observed to have significantly reduced diastolic arterial pressure compared to their
controls during the recovery period, but this is may be a limitation of n, as the mean and
systolic arterial pressures remained reduced compared to controls during this time period.
If the reductions in mean arterial and systolic arterial pressure in the hypothyroid
SHRs were due to a reduction in resistance or blood volume, we would anticipate a
corresponding reduction in diastolic pressure. However, the SHR hypothyroid rats did not
experience a reduction in diastolic pressure indicating that the reductions in mean arterial
and systolic arterial pressure are most likely due to the reduction in stroke volume (Danzi
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& Klein, 2003; Polikar, Burger, Scherrer, & Nicod, 1993) and reductions in contractility
and ejection speed observed in hypothyroidism.
A potential explanation of the difference in effect of hypothyroid treatment on
diastolic arterial pressure between strains could be endothelial dysfunction (Kung &
Luscher) observed in SHRs. Evidence suggests that SHRs have altered endothelial
function (Mirsky, Pfeffer, Pfeffer, & Braunwald). Interestingly, thyroid hormone
signaling is involved in the synthesis of nitric oxide (Virdis et al.). Considering this, an
impaired ability of the endothelium to release vasodilatory paracrine agents may indicate
that the SHR is especially dependent on thyroid mediated nitric oxide synthesis.
Sustained reductions in systolic, diastolic, and mean arterial pressures in
hypothyroid animals persisted, even after three weeks of treatment withdrawal, which is
contrary to previous studies (Rioux & Berkowitz) and is indicative of lasting
morphological changes induced by hypothyroidism at weaning. Studies of gestational
hypothyroidism have reported permanent increases in blood pressure despite return to
euthyroid status and have outlined changes in the autonomic nervous system’s control of
blood pressure as a cause (Mittag, Davis, Vujovic, Arner, & Vennstrom; Santos et al.). It
is possible that treatment at weaning also induced changes in autonomic nervous system
control of blood pressure. A decrease in blood pressure rather than increase may be due
to a difference in timing of hypothyroidism.
The reductions in pulse pressure and heart rate in hypothyroid SHRs and
hypothyroid WKY animals compared to their respective controls are consistent with
clinical observations of reduced heart rate and pulse pressure in hypothyroid human
patients. However, the reduction in pulse pressure observed clinically is typically due to
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diastolic hypertension, not systolic hypotension, which was observed in hypothyroid
SHRs the present study. As prior clinical studies observed adult onset hypothyroidism
and subclinical hypothyroidism, the difference in timing of the onset of hypothyroidism
in the present study is a potential explanation for these differences. The observed
differences in effect of hypothyroid treatment on pulse pressure between strains could be
due to increased arterial stiffness (Safar, Chamiot-Clerc, Dagher, & Renaud) and left
ventricular dysfunction (Mirsky et al.) observed in SHRs. Increased arterial stiffness in
SHRs compared to WKYs provides an explanation for the high pulse pressure observed
in control SHRs. Left ventricular dysfunction has been observed in hypothyroidism
(Biondi et al.) and may be due to alterations in myosin chain expression that have been
observed in hypothyroidism (I. Klein & Danzi). Considering that diastolic function is
impaired in euthyroid SHR, SHRs may be more vulnerable to alterations in myosin chain
expression.
While hypothyroid SHRs exhibited a smaller reduction in heart rate compared to
WKYs, the heart rates of the two hypothyroid groups did not significantly differ. This
difference in reduction in heart rate is most likely due to the lower baseline heart rate of
the SHR compared to that of the WKY(van den Buuse).
A strain specific increase in pressure natriuresis was observed in WKY
hypothyroid rats compared to WKY controls, but in hypothyroid SHRs, a non-significant
increase in pressure natriuresis was measured. If these acute observations are
representative of chronic kidney behavior, WKY hypothyroid animals may experience a
reduction in blood volume compared to controls. This is consistent with the reduced
blood volume observed in hypothyroidism in humans (Danzi & Klein, 2003) and may
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provide another potential explanation for the strain specific reduction in diastolic arterial
pressure under treatment in WKY rats.
Additionally, pressure natriuresis is related to endothelial function and endothelial
function is impaired in the SHR (Mirsky et al.). Nitric oxide has known involvement in
pressure natriuresis (Guarasci & Kline) and thyroid hormone signaling is involved in its
synthesis (Virdis et al.). Since nitric oxide synthase inhibition is associated with
decreased pressure natriuresis and nitric oxide synthase is positively regulated by thyroid
hormone, augmented pressure natriuresis in hyperthyroidism and blunted pressure
natriuresis in hypothyroidism would be anticipated. However, hyperthyroidism blunts the
pressure natriuresis response in rats, but chronic hypothyroidism is not associated with an
alteration of the pressure natriuresis response (Vargas et al., 1994) and the present study
found augmented pressure natriuresis in hypothyroid WKYs compared to the controls .
This suggests that alternative mechanisms regulating pressure natriuresis compensate for
chronic reduction of nitric oxide synthase activity associated with hypothyroidism.
Thyroid hormone’s effect on the synthesis of nitric oxide may be of greater importance in
the SHR, due to the underlying endothelial dysfunction, and they may lack the natriuretic
compensatory mechanism that appears to be present in the WKY. This may be a potential
explanation as to why hypothyroid SHRs did not experience a significant elevation in
pressure natriuresis when compared to their controls. This finding also emphasizes that
hypothyroidism likely induces a multifaceted effect on the cardiovascular system.
Although there is clear evidence that thyroid hormone has direct effects on the
heart, vasculature and autonomic nervous control of blood pressure, hypothyroidism is a
systemic condition and it cannot be ruled out that the observed effects are the result of an
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indirect effect. For example, induction of hypothyroidism through thyroid inhibition
increases TSH and TRH by removing negative feedback inhibition as well as disrupting
other hormone pathways (Brent, 2012; Burstein, Draznin, Johnson, & Schalch; Miell et
al., 1993). It is therefore possible that some effects observed in the present study are due
to effects related to treatment and are not directly associated with thyroid hormone action.
However, given that prior literature identifies direct and indirect action of thyroid
hormone on the cardiovascular system, it is a reasonable assumption that the observations
of the present study are due to direct and indirect effects of reduced thyroid hormone.
Weight gain is associated with an increase in blood pressure (Masuo, Mikami,
Ogihara, & Tuck) and it is possible that effects seen in the present study were related to
growth retardation induced by hypothyroidism. However, the recovery subset of rats in
the present study did not experience a significant increase in systolic or mean arterial
pressure, despite returning to euthyroid status and gaining weight. This observation
suggests that growth retardation was not the cause of the reductions in systolic and mean
arterial pressure experienced by hypothyroid animals.
In revisiting our hypotheses, we reach several conclusions. First, inhibition of
thyroid gland activity resulted in a decrease in mean arterial pressure in SHRs when
compared to controls that was equal to the decrease found in WKY rats given the same
treatment. This finding indicates abnormal thyroid hormone action following weaning is
not a major factor in the development of hypertension in the SHR. However, differences
in response to treatment in diastolic arterial pressure and pulse pressure between the SHR
and WKY rats are indicative of strain differences of thyroid hormone action in
cardiovascular system.
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Second, inhibition of thyroid gland activity in SHRs resulted in a smaller increase
in systolic arterial pressure in response to acute stress when compared to euthyroid SHRs,
but no significant differences in stress response were observed between hypothyroid and
control WKYs. This indicates that hypothyroid treatment reduced the effect of
sympathetic stimulation on systolic arterial pressure in SHRs, but not in WKY rats.
Lastly, hypothyroid treatment resulted in significantly greater pressure natriuresis
in WKY rats when compared to WKY euthyroid controls. However, no significant
differences in increases in pressure natriuresis were found between control SHRs and
hypothyroid SHRs. This indicates that sustained hypothyroidism beginning at weaning
increases the pressure natriuresis response in WKY rats, but not SHR.

References
Amidi, M., Leon, D. F., DeGroot, W. J., Kroetz, F. W., & Leonard, J. J. (1968). Effect of
the thyroid state on myocardial contractility and ventricular ejection rate in man.
Circulation, 38(2), 229-239.
Aoki, K. (1963a). Experimental Studies on the Relationship between Endocrine Organs
and Hypertension in Spontaneously Hypertensive Rats. I. Effects of
Hypophysectomy, Adrenalectomy, Thyroidectomy, Nephrectomy and
Sympathectomy on Blood Pressure. Jpn Heart J, 4, 443-461.
Aoki, K. (1963b). Experimental Studies on the Relationship between Endocrine Organs
and Hypertension in Spontaneously Hypertensive Rats. Ii. Effects of Various
Hormones on Blood Pressure. Jpn Heart J, 56, 561-576.
Bachman, E. S., Hampton, T. G., Dhillon, H., Amende, I., Wang, J., Morgan, J. P., &
Hollenberg, A. N. (2004). The metabolic and cardiovascular effects of
hyperthyroidism are largely independent of beta-adrenergic stimulation.
Endocrinology, 145(6), 2767-2774. doi: 10.1210/en.2003-1670
Bates, J. M., St Germain, D. L., & Galton, V. A. (1999). Expression profiles of the three
iodothyronine deiodinases, D1, D2, and D3, in the developing rat. Endocrinology,
140(2), 844-851. doi: 10.1210/endo.140.2.6537
Bilezikian, J. P., & Loeb, J. N. (1983). The influence of hyperthyroidism and
hypothyroidism on alpha- and beta-adrenergic receptor systems and adrenergic
responsiveness. Endocr Rev, 4(4), 378-388. doi: 10.1210/edrv-4-4-378

45

Biondi, B., Fazio, S., Palmieri, E. A., Carella, C., Panza, N., Cittadini, A., . . . Sacca, L.
(1999). Left ventricular diastolic dysfunction in patients with subclinical
hypothyroidism. J Clin Endocrinol Metab, 84(6), 2064-2067. doi:
10.1210/jcem.84.6.5733
Brent, G. A. (2012). Mechanisms of thyroid hormone action. J Clin Invest, 122(9), 30353043. doi: 10.1172/JCI60047
Buccino, R. A., Spann, J. F., Jr., Pool, P. E., Sonnenblick, E. H., & Braunwald, E. (1967).
Influence of the thyroid state on the intrinsic contractile properties and energy
stores of the myocardium. J Clin Invest, 46(10), 1669-1682. doi:
10.1172/JCI105658
Burstein, P. J., Draznin, B., Johnson, C. J., & Schalch, D. S. (1979). The effect of
hypothyroidism on growth, serum growth hormone, the growth hormonedependent somatomedin, insulin-like growth factor, and its carrier protein in rats.
Endocrinology, 104(4), 1107-1111. doi: 10.1210/endo-104-4-1107
Cheng, S. Y., Leonard, J. L., & Davis, P. J. (2010). Molecular aspects of thyroid hormone
actions. Endocr Rev, 31(2), 139-170. doi: 10.1210/er.2009-0007
Chiueh, C. C., & Kopin, I. J. (1978). Hyperresponsivitiy of spontaneously hypertensive
rat to indirect measurement of blood pressure. Am J Physiol, 234(6), H690-695.
Dainiak, N., Hoffman, R., Maffei, L. A., & Forget, B. G. (1978). Potentiation of human
erythropoiesis in vitro by thyroid hormone. Nature, 272(5650), 260-262.
Danzi, S., & Klein, I. (2003). Thyroid hormone and blood pressure regulation. Curr
Hypertens Rep, 5(6), 513-520.
Fletcher, A. K., & Weetman, A. P. (1998). Hypertension and hypothyroidism. J Hum
Hypertens, 12(2), 79-82.
Fliers, E., Klieverik, L. P., & Kalsbeek, A. (2010). Novel neural pathways for metabolic
effects of thyroid hormone. Trends Endocrinol Metab, 21(4), 230-236. doi:
10.1016/j.tem.2009.11.008
Fregly, M. J. (1975). Thyroid activity of spontaneous hypertensive rats. Proc Soc Exp
Biol Med, 149(1), 124-132.
Gard, P. R. (1998). Human endocrinology. London ; Bristol, PA: Taylor & Francis.
Guarasci, G. R., & Kline, R. L. (1996). Pressure natriuresis following acute and chronic
inhibition of nitric oxide synthase in rats. Am J Physiol, 270(2 Pt 2), R469-478.
Hak, A. E., Pols, H. A., Visser, T. J., Drexhage, H. A., Hofman, A., & Witteman, J. C.
(2000). Subclinical hypothyroidism is an independent risk factor for
atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study.
Ann Intern Med, 132(4), 270-278.
Hamilton, M. A., Stevenson, L. W., Fonarow, G. C., Steimle, A., Goldhaber, J. I., Child,
J. S., . . . Hage, A. (1998). Safety and hemodynamic effects of intravenous
triiodothyronine in advanced congestive heart failure. Am J Cardiol, 81(4), 443447.
Kiss, E., Brittsan, A. G., Edes, I., Grupp, I. L., Grupp, G., & Kranias, E. G. (1998).
Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts.
Circ Res, 83(6), 608-613.
Kiss, E., Jakab, G., Kranias, E. G., & Edes, I. (1994). Thyroid hormone-induced
alterations in phospholamban protein expression. Regulatory effects on

46

sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. Circ Res,
75(2), 245-251.
Klein, I., & Danzi, S. (2007). Thyroid disease and the heart. Circulation, 116(15), 17251735. doi: 10.1161/CIRCULATIONAHA.106.678326
Klein, I., & Ojamaa, K. (2001). Thyroid hormone and the cardiovascular system. N Engl
J Med, 344(7), 501-509. doi: 10.1056/NEJM200102153440707
Klein, I. L., G.S. (2000). The cardivascular system in thyrotoxicosis. In U. R. Braverman
LE (Ed.), Werner & INgbar's the thyroid: a fundamental and clinical text (pp.
596-604). Philidelphia: Lippincott Williams & Wilkins.
Klemperer, J. D., Klein, I., Gomez, M., Helm, R. E., Ojamaa, K., Thomas, S. J., . . .
Krieger, K. (1995). Thyroid hormone treatment after coronary-artery bypass
surgery. N Engl J Med, 333(23), 1522-1527. doi:
10.1056/NEJM199512073332302
Kojima, A., Kubota, T., Sato, A., Yamada, T., & Harada, A. (1976). Abnormal thyroid
function in spontaneously hypertensive rats. Endocrinology, 98(5), 1109-1115.
doi: 10.1210/endo-98-5-1109
Korecky, B., Zak, R., Schwartz, K., & Aschenbrenner, V. (1987). Role of thyroid
hormone in regulation of isomyosin composition, contractility, and size of
heterotopically isotransplanted rat heart. Circ Res, 60(6), 824-830.
Krenz, M., & Robbins, J. (2004). Impact of beta-myosin heavy chain expression on
cardiac function during stress. J Am Coll Cardiol, 44(12), 2390-2397. doi:
10.1016/j.jacc.2004.09.044
Kung, C. F., & Luscher, T. F. (1995). Different mechanisms of endothelial dysfunction
with aging and hypertension in rat aorta. Hypertension, 25(2), 194-200.
Lopez, M., Varela, L., Vazquez, M. J., Rodriguez-Cuenca, S., Gonzalez, C. R.,
Velagapudi, V. R., . . . Vidal-Puig, A. (2010). Hypothalamic AMPK and fatty
acid metabolism mediate thyroid regulation of energy balance. Nat Med, 16(9),
1001-1008. doi: 10.1038/nm.2207
Louch, W. E., Hougen, K., Mork, H. K., Swift, F., Aronsen, J. M., Sjaastad, I., . . .
Sejersted, O. M. (2010). Sodium accumulation promotes diastolic dysfunction in
end-stage heart failure following Serca2 knockout. J Physiol, 588(Pt 3), 465-478.
doi: 10.1113/jphysiol.2009.183517
Mansen, A., Yu, F., Forrest, D., Larsson, L., & Vennstrom, B. (2001). TRs have common
and isoform-specific functions in regulation of the cardiac myosin heavy chain
genes. Mol Endocrinol, 15(12), 2106-2114. doi: 10.1210/mend.15.12.0735
Masuo, K., Mikami, H., Ogihara, T., & Tuck, M. L. (2000). Weight gain-induced blood
pressure elevation. Hypertension, 35(5), 1135-1140.
Miell, J. P., Taylor, A. M., Zini, M., Maheshwari, H. G., Ross, R. J., & Valcavi, R.
(1993). Effects of hypothyroidism and hyperthyroidism on insulin-like growth
factors (IGFs) and growth hormone- and IGF-binding proteins. J Clin Endocrinol
Metab, 76(4), 950-955. doi: 10.1210/jcem.76.4.7682563
Mirsky, I., Pfeffer, J. M., Pfeffer, M. A., & Braunwald, E. (1983). The contractile state as
the major determinant in the evolution of left ventricular dysfunction in the
spontaneously hypertensive rat. Circ Res, 53(6), 767-778.
Mittag, J., Davis, B., Vujovic, M., Arner, A., & Vennstrom, B. (2010). Adaptations of the
autonomous nervous system controlling heart rate are impaired by a mutant

47

thyroid hormone receptor-alpha1. Endocrinology, 151(5), 2388-2395. doi:
10.1210/en.2009-1201
Mittag, J., Lyons, D. J., Sallstrom, J., Vujovic, M., Dudazy-Gralla, S., Warner, A., . . .
Vennstrom, B. (2013). Thyroid hormone is required for hypothalamic neurons
regulating cardiovascular functions. J Clin Invest, 123(1), 509-516. doi:
10.1172/JCI65252
Mohrman, D. E., & Heller, L. J. (1997). Cardiovascular physiology (4th ed.). New York:
McGraw-Hill, Health Professions Division.
Obuobie, K., Smith, J., Evans, L. M., John, R., Davies, J. S., & Lazarus, J. H. (2002).
Increased central arterial stiffness in hypothyroidism. J Clin Endocrinol Metab,
87(10), 4662-4666. doi: 10.1210/jc.2002-020493
Ojamaa, K., Klemperer, J. D., & Klein, I. (1996). Acute effects of thyroid hormone on
vascular smooth muscle. Thyroid, 6(5), 505-512.
Park, K. W., Dai, H. B., Ojamaa, K., Lowenstein, E., Klein, I., & Sellke, F. W. (1997).
The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance
arteries. Anesth Analg, 85(4), 734-738.
Polikar, R., Burger, A. G., Scherrer, U., & Nicod, P. (1993). The thyroid and the heart.
Circulation, 87(5), 1435-1441.
Rahmani, M. A., Cheema, I. R., Sen, S., Peoples, B., & Riley, S. R. (1987). The effect of
hyperthyroidism and hypothyroidism on alpha 1- and alpha 2-adrenergic
responsiveness in rat aortic smooth muscle. Artery, 14(6), 362-383.
Resnick, L. M., & Laragh, J. H. (1982). PLasma renin activity in syndromes of thyroid
hormone excess and deficiency. Life Sci, 30(7-8), 585-586.
Rhee, C. M., Curhan, G. C., Alexander, E. K., Bhan, I., & Brunelli, S. M. (2013).
Subclinical hypothyroidism and survival: the effects of heart failure and race. J
Clin Endocrinol Metab, 98(6), 2326-2336. doi: 10.1210/jc.2013-1039
Rioux, F., & Berkowitz, B. A. (1977). Role of the thyroid gland in the development and
maintenance of spontaneous hypertension in rats. Circ Res, 40(3), 306-312.
Safar, M., Chamiot-Clerc, P., Dagher, G., & Renaud, J. F. (2001). Pulse pressure,
endothelium function, and arterial stiffness in spontaneously hypertensive rats.
Hypertension, 38(6), 1416-1421.
Saito, I., Ito, K., & Saruta, T. (1983). Hypothyroidism as a cause of hypertension.
Hypertension, 5(1), 112-115.
Saito, I., & Saruta, T. (1994). Hypertension in thyroid disorders. Endocrinol Metab Clin
North Am, 23(2), 379-386.
Santos, S. O., Loureiro, S. M., Alves, I. G., Jesus, C. S., Santos, P. R., Santos, M. R., . . .
Badaue-Passos, D., Jr. (2012). Experimental gestational hypothyroidism evokes
hypertension in adult offspring rats. Auton Neurosci, 170(1-2), 36-41. doi:
10.1016/j.autneu.2012.07.004
Streeten, D. H., Anderson, G. H., Jr., Howland, T., Chiang, R., & Smulyan, H. (1988).
Effects of thyroid function on blood pressure. Recognition of hypothyroid
hypertension. Hypertension, 11(1), 78-83.
van den Buuse, M. (1994). Circadian rhythms of blood pressure, heart rate, and
locomotor activity in spontaneously hypertensive rats as measured with radiotelemetry. Physiol Behav, 55(4), 783-787.

48

Vargas, F., Atucha, N. M., Sabio, J. M., Quesada, T., & Garcia-Estan, J. (1994).
Pressure-diuresis-natriuresis response in hyperthyroid and hypothyroid rats. Clin
Sci (Lond), 87(3), 323-328.
Virdis, A., Colucci, R., Fornai, M., Polini, A., Daghini, E., Duranti, E., . . . Monzani, F.
(2009). Inducible nitric oxide synthase is involved in endothelial dysfunction of
mesenteric small arteries from hypothyroid rats. Endocrinology, 150(2), 10331042. doi: 10.1210/en.2008-1112
Werner, S. C., Manger, W. M., Radichevich, I., Wolff, M., & von Estorff, I. (1975).
Excessive thyrotropin concentrations in the circulation of the spontaneously
hypertensive rat. Proc Soc Exp Biol Med, 148(4), 1013-1017.
Yamabe, H. (1970). Studies on the thyroid in spontaneously hypertensive rats. I. Thyroid
activity. Jpn Circ J, 34(4), 233-244.

